Literature DB >> 29778819

Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).

Govindan Rajivgandhi1, Muthuchamy Maruthupandy2, Natesan Manoharan3.   

Abstract

The multidrug resistant Gram negative bacteria (MDRGNB) is an emerging burden and now represents a daily challenge for the management of antimicrobial therapy in healthcare settings. The present study was aimed to detect the prevalence of TEM and CTX-M type genes from GNB on urinary tract infection (UTIs). The ciprofloxacin resistant uropathogens were detected by HEXA UTI 5 disc diffusion method. The phenotypic detection of uropathogens producing extended spectrum beta lactamases (ESBLs) was confirmed by double disc combination test (DDCT) and phenotype confirmation test (PCT). The prevalence of TEM and CTX-M genes of uropathogens was identified by multiplex PCR analysis. The in vitro antimicrobial susceptibility of E. coli producing ESBL (26), 21 isolates of P. mirabilis, 17 P. aeruginosa, 14 K. pneumoniae and 6 Enterobacter sp. were detected. Based on the extension of the cephalosporin zone edge towards augmentin disc in the DDST method proved 84% of the isolates were ESBL positive. Similar results were obtained in phenotypic confirmatory test (PCT) by the increases of ≥5 mm zone of inhibition in the combination disc when compared with ceftazidime disc alone. The prevalence of TEM and CTX-M genes were determined from multidrug resistance uropathogens (MDU) respectively as 83%, 75%, 71%, 63%, 60%, 55%, 54%, 50%. The most prevalent (TEM + CTX-M) genes were also detected in ciprofloxacin resistant strains P. mirabilis BDUMS1 (KY617768) and E. coli BDUMS3 (KY617770). Due to the increase of ESBL genes in uropathogens, sustained supervision for using favorable antibiotics and decreasing the infection is essential.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Extended spectrum beta lactamase; Gram negative bacteria; Urinary tract infections

Mesh:

Substances:

Year:  2018        PMID: 29778819     DOI: 10.1016/j.micpath.2018.05.024

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  4 in total

1.  Characterization of Hypervirulent Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Among Urinary Tract Infections: The First Report from Iran.

Authors:  Azadeh Taraghian; Bahram Nasr Esfahani; Sharareh Moghim; Hossein Fazeli
Journal:  Infect Drug Resist       Date:  2020-09-09       Impact factor: 4.003

Review 2.  Examination of Complementary Medicine for Treating Urinary Tract Infections Among Pregnant Women and Children.

Authors:  Rachel E Hudson; Kathleen M Job; Casey L Sayre; Lubov V Krepkova; Catherine M Sherwin; Elena Y Enioutina
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

3.  DNA Gyrase and Topoisomerase IV Mutations and their effect on Quinolones Resistant Proteus mirabilis among UTIs Patients.

Authors:  Randa H Abdelkreem; Amjad M Yousuf; Miskelyemen A Elmekki; Mogahid M Elhassan
Journal:  Pak J Med Sci       Date:  2020 Sep-Oct       Impact factor: 1.088

4.  Identification of carbapenems resistant genes on biofilm forming K. pneumoniae from urinary tract infection.

Authors:  Govindan Nadar Rajivgandhi; Naiyf S Alharbi; Shine Kadaikunnan; Jamal M Khaled; Chelliah Chenthis Kanisha; Govindan Ramachandran; Natesan Manoharan; Khalid F Alanzi
Journal:  Saudi J Biol Sci       Date:  2020-12-29       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.